Biography of Mark Pruzanski

Last update: February 13, 2024

Career

Mark was Chief Executive Officer at Versanis Bio, and Chief Executive Officer and Director at Intercept Pharmaceuticals. Mark Pruzanski joined Eli Lilly in 2023.

Mark Pruzanski is currently

Create your alert
to follow the career of Mark Pruzanski.

Education

Mark Pruzanski has a Master of Arts in International Relations and Affairs from Johns Hopkins School of Advanced International Studies and a Doctor of Medicine from McMaster University.

They have also studied at McMaster University :

Find more alumni from McMaster University

More about Mark Pruzanski

The colleagues of Mark Pruzanski

Company Colleagues
Homonyms
Industry Colleagues
  • In the Biotechnology industry, Mark Pruzanski has 30,131 colleagues in 2,273 companies located in 41 countries. 14,386 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Mark Pruzanski.

Get in Touch

Use our Premium/VIP Service to contact Mark Pruzanski by email now. Here are a few tips for establishing great contacts.

Send an email
to Mark Pruzanski.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.